

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.20577807 |
| 2 | vocalization behavior (GO:0071625) | 5.88128292 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.85975325 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.83185698 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.78553679 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.61485481 |
| 7 | glutamate secretion (GO:0014047) | 5.43519511 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.38602502 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.32171074 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10758817 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.01214226 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.98058524 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.88514166 |
| 14 | protein localization to synapse (GO:0035418) | 4.83290156 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.74935727 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.66018005 |
| 17 | exploration behavior (GO:0035640) | 4.62569649 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.60365405 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.58089506 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.55696554 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.47556467 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.45773029 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.44048992 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 4.42375727 |
| 25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.34707632 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 4.31490442 |
| 27 | L-amino acid import (GO:0043092) | 4.25131508 |
| 28 | gamma-aminobutyric acid transport (GO:0015812) | 4.19951352 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 4.06773285 |
| 30 | long-term memory (GO:0007616) | 4.02997865 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.02678940 |
| 32 | proline transport (GO:0015824) | 3.97247480 |
| 33 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.94645014 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93318527 |
| 35 | positive regulation of membrane potential (GO:0045838) | 3.91659981 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.90880546 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.81269049 |
| 38 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.79466860 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.77523582 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.74575098 |
| 41 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.74115080 |
| 42 | regulation of synaptic plasticity (GO:0048167) | 3.73542390 |
| 43 | cellular potassium ion homeostasis (GO:0030007) | 3.71225808 |
| 44 | detection of calcium ion (GO:0005513) | 3.71168815 |
| 45 | neurotransmitter transport (GO:0006836) | 3.70334439 |
| 46 | amino acid import (GO:0043090) | 3.69831365 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.65726917 |
| 48 | * regulation of synapse structural plasticity (GO:0051823) | 3.65317336 |
| 49 | serotonin metabolic process (GO:0042428) | 3.60724366 |
| 50 | positive regulation of dendritic spine development (GO:0060999) | 3.60668801 |
| 51 | long-term synaptic potentiation (GO:0060291) | 3.59559855 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.57717626 |
| 53 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.56602604 |
| 54 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.56274042 |
| 55 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.54936098 |
| 56 | potassium ion homeostasis (GO:0055075) | 3.53799812 |
| 57 | neuron recognition (GO:0008038) | 3.52721491 |
| 58 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.52428048 |
| 59 | cellular sodium ion homeostasis (GO:0006883) | 3.51681916 |
| 60 | activation of protein kinase A activity (GO:0034199) | 3.48955256 |
| 61 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.48898919 |
| 62 | postsynaptic membrane organization (GO:0001941) | 3.46827261 |
| 63 | regulation of neurotransmitter levels (GO:0001505) | 3.45455624 |
| 64 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.44656888 |
| 65 | regulation of neurotransmitter secretion (GO:0046928) | 3.41078609 |
| 66 | neuromuscular process controlling balance (GO:0050885) | 3.40513061 |
| 67 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.39215165 |
| 68 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.37788588 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 3.37682108 |
| 70 | response to histamine (GO:0034776) | 3.37197100 |
| 71 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35452135 |
| 72 | neuronal ion channel clustering (GO:0045161) | 3.31770962 |
| 73 | behavioral defense response (GO:0002209) | 3.31540189 |
| 74 | behavioral fear response (GO:0001662) | 3.31540189 |
| 75 | presynaptic membrane assembly (GO:0097105) | 3.31408525 |
| 76 | auditory behavior (GO:0031223) | 3.31035120 |
| 77 | axonal fasciculation (GO:0007413) | 3.29142855 |
| 78 | sodium ion export (GO:0071436) | 3.29086879 |
| 79 | potassium ion import (GO:0010107) | 3.24061357 |
| 80 | membrane depolarization (GO:0051899) | 3.23164466 |
| 81 | response to auditory stimulus (GO:0010996) | 3.22634475 |
| 82 | cerebellar granule cell differentiation (GO:0021707) | 3.20083836 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.18610006 |
| 84 | positive regulation of neurotransmitter transport (GO:0051590) | 3.17872399 |
| 85 | regulation of vesicle fusion (GO:0031338) | 3.17267810 |
| 86 | learning (GO:0007612) | 3.17161510 |
| 87 | neuromuscular process controlling posture (GO:0050884) | 3.16236778 |
| 88 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.15691958 |
| 89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.14445235 |
| 90 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.14086993 |
| 91 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.13765150 |
| 92 | synapse assembly (GO:0007416) | 3.13346869 |
| 93 | primary amino compound metabolic process (GO:1901160) | 3.11062731 |
| 94 | response to amphetamine (GO:0001975) | 3.10920868 |
| 95 | membrane hyperpolarization (GO:0060081) | 3.10726957 |
| 96 | membrane depolarization during action potential (GO:0086010) | 3.10069987 |
| 97 | nucleobase catabolic process (GO:0046113) | 3.09013229 |
| 98 | cell differentiation in hindbrain (GO:0021533) | 3.08772638 |
| 99 | fear response (GO:0042596) | 3.08747104 |
| 100 | dendrite morphogenesis (GO:0048813) | 3.08141419 |
| 101 | central nervous system myelination (GO:0022010) | 3.08132062 |
| 102 | axon ensheathment in central nervous system (GO:0032291) | 3.08132062 |
| 103 | presynaptic membrane organization (GO:0097090) | 3.07488583 |
| 104 | regulation of synaptic transmission (GO:0050804) | 3.07334361 |
| 105 | synaptic transmission (GO:0007268) | 3.07188009 |
| 106 | regulation of synapse maturation (GO:0090128) | 3.06711488 |
| 107 | innervation (GO:0060384) | 3.05094821 |
| 108 | intraspecies interaction between organisms (GO:0051703) | 3.05043304 |
| 109 | social behavior (GO:0035176) | 3.05043304 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 3.04074037 |
| 111 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04005754 |
| 112 | regulation of ARF protein signal transduction (GO:0032012) | 3.03921436 |
| 113 | neuromuscular process (GO:0050905) | 3.03454833 |
| 114 | establishment of synaptic vesicle localization (GO:0097480) | 3.02816438 |
| 115 | synaptic vesicle transport (GO:0048489) | 3.02816438 |
| 116 | startle response (GO:0001964) | 3.02742126 |
| 117 | behavioral response to cocaine (GO:0048148) | 3.02686896 |
| 118 | regulation of dendritic spine development (GO:0060998) | 3.02133585 |
| 119 | vesicle transport along microtubule (GO:0047496) | 3.00901491 |
| 120 | long term synaptic depression (GO:0060292) | 3.00889979 |
| 121 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.99137595 |
| 122 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97273946 |
| 123 | prepulse inhibition (GO:0060134) | 2.96252736 |
| 124 | cell communication by electrical coupling (GO:0010644) | 2.94644579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.13335047 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.77332105 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18875585 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.13051737 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.08991657 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.72880510 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.72880510 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.67804839 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65502578 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58187862 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.54050763 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50957418 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50888076 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50208893 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48859286 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47525683 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40575606 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21322480 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18523336 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16329184 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15966112 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15810947 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.09293059 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.02583690 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99749030 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.92013993 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.91930545 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91583114 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.90961185 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87965107 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85366542 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76992711 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76581120 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71955011 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66687766 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54530533 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52544157 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49011006 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47742487 |
| 40 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.45825901 |
| 41 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42195648 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36921919 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35732124 |
| 44 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34329315 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32968388 |
| 46 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32493806 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30140737 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29989082 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29573189 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28375642 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28097525 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26499260 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25841332 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23539537 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23414875 |
| 56 | * AR_19668381_ChIP-Seq_PC3_Human | 1.23317248 |
| 57 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22767929 |
| 58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22739597 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19816592 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17676895 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16950626 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15626969 |
| 63 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15305745 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13978959 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13961744 |
| 66 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.13569370 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12692401 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12300151 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12235162 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11914032 |
| 71 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11699859 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11455447 |
| 73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09598078 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09066380 |
| 75 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08282678 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07673003 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07072388 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06997665 |
| 79 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06637756 |
| 80 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05336658 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04965799 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04287059 |
| 83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04221888 |
| 84 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03620561 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02790990 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02688155 |
| 87 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.02458407 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00699802 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99939701 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99796063 |
| 91 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98978339 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98155401 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97899651 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96527168 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96348379 |
| 96 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95481395 |
| 97 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94043077 |
| 98 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93561077 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93216978 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92683723 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92503959 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92187759 |
| 103 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91679032 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91651747 |
| 105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91094702 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90633776 |
| 107 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89515074 |
| 108 | JUN_21703547_ChIP-Seq_K562_Human | 0.89443617 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89222083 |
| 110 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88797022 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88683690 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88291999 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87987169 |
| 114 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87564835 |
| 115 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.87088361 |
| 116 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87086512 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86617240 |
| 118 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86605116 |
| 119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86112331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.73509811 |
| 2 | MP0003880_abnormal_central_pattern | 4.63331396 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.32184177 |
| 4 | MP0004270_analgesia | 3.73055058 |
| 5 | MP0009745_abnormal_behavioral_response | 3.65241803 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.51414982 |
| 7 | MP0009046_muscle_twitch | 3.41694743 |
| 8 | MP0002064_seizures | 3.33332043 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.07925723 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.97936250 |
| 11 | MP0002822_catalepsy | 2.78344724 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.76178541 |
| 13 | MP0002272_abnormal_nervous_system | 2.73710384 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.65509339 |
| 15 | MP0001486_abnormal_startle_reflex | 2.60100392 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.56178382 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.38443073 |
| 18 | MP0002736_abnormal_nociception_after | 2.36774057 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.27248103 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.07003814 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.05121673 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.03217881 |
| 23 | MP0001970_abnormal_pain_threshold | 1.99398475 |
| 24 | MP0008569_lethality_at_weaning | 1.98925881 |
| 25 | MP0003329_amyloid_beta_deposits | 1.88623363 |
| 26 | MP0002557_abnormal_social/conspecific_i | 1.85143090 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.80980072 |
| 28 | MP0004924_abnormal_behavior | 1.80980072 |
| 29 | MP0002184_abnormal_innervation | 1.80443576 |
| 30 | MP0003879_abnormal_hair_cell | 1.77734973 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.76847321 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.75761907 |
| 33 | MP0004858_abnormal_nervous_system | 1.70099615 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.69376848 |
| 35 | MP0000778_abnormal_nervous_system | 1.68618451 |
| 36 | MP0001984_abnormal_olfaction | 1.61575928 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.59580847 |
| 38 | MP0000955_abnormal_spinal_cord | 1.46729172 |
| 39 | MP0003787_abnormal_imprinting | 1.45993624 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.43929749 |
| 41 | MP0004885_abnormal_endolymph | 1.41613954 |
| 42 | MP0003633_abnormal_nervous_system | 1.39819179 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.37627085 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.32210691 |
| 45 | MP0001905_abnormal_dopamine_level | 1.28851397 |
| 46 | MP0001529_abnormal_vocalization | 1.21493616 |
| 47 | MP0004142_abnormal_muscle_tone | 1.20484057 |
| 48 | MP0003631_nervous_system_phenotype | 1.19996418 |
| 49 | MP0008872_abnormal_physiological_respon | 1.15873223 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.11491304 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.08125923 |
| 52 | MP0002152_abnormal_brain_morphology | 1.06345169 |
| 53 | MP0001188_hyperpigmentation | 1.04801690 |
| 54 | MP0003122_maternal_imprinting | 1.02546042 |
| 55 | MP0008874_decreased_physiological_sensi | 1.02354316 |
| 56 | MP0004147_increased_porphyrin_level | 1.01404260 |
| 57 | MP0005394_taste/olfaction_phenotype | 1.00785304 |
| 58 | MP0005499_abnormal_olfactory_system | 1.00785304 |
| 59 | MP0001177_atelectasis | 0.99835848 |
| 60 | MP0003123_paternal_imprinting | 0.99310059 |
| 61 | MP0002229_neurodegeneration | 0.93177776 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 0.91568076 |
| 63 | MP0005535_abnormal_body_temperature | 0.91504241 |
| 64 | MP0002069_abnormal_eating/drinking_beha | 0.91309066 |
| 65 | MP0008877_abnormal_DNA_methylation | 0.90667093 |
| 66 | MP0000751_myopathy | 0.89904376 |
| 67 | MP0005623_abnormal_meninges_morphology | 0.89616192 |
| 68 | MP0003690_abnormal_glial_cell | 0.88512036 |
| 69 | MP0004085_abnormal_heartbeat | 0.86272808 |
| 70 | MP0000604_amyloidosis | 0.85667812 |
| 71 | MP0004742_abnormal_vestibular_system | 0.85642598 |
| 72 | MP0003632_abnormal_nervous_system | 0.85272254 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.84152908 |
| 74 | MP0003075_altered_response_to | 0.81157774 |
| 75 | MP0004484_altered_response_of | 0.80925118 |
| 76 | MP0000013_abnormal_adipose_tissue | 0.80796532 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 0.79443343 |
| 78 | MP0001348_abnormal_lacrimal_gland | 0.79041023 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.76879754 |
| 80 | MP0004215_abnormal_myocardial_fiber | 0.75334226 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.71361422 |
| 82 | MP0003634_abnormal_glial_cell | 0.71072518 |
| 83 | MP0004043_abnormal_pH_regulation | 0.68965228 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.68251945 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 0.67720254 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.67701562 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.67118510 |
| 88 | MP0000920_abnormal_myelination | 0.64940447 |
| 89 | MP0003283_abnormal_digestive_organ | 0.64389833 |
| 90 | MP0004233_abnormal_muscle_weight | 0.62514499 |
| 91 | MP0002090_abnormal_vision | 0.62496543 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.62430949 |
| 93 | MP0001664_abnormal_digestion | 0.60360451 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.60192204 |
| 95 | MP0003646_muscle_fatigue | 0.58893570 |
| 96 | MP0004510_myositis | 0.58871854 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.58720051 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.56916207 |
| 99 | MP0005409_darkened_coat_color | 0.56533213 |
| 100 | MP0003121_genomic_imprinting | 0.54950823 |
| 101 | MP0001943_abnormal_respiration | 0.53807734 |
| 102 | MP0010769_abnormal_survival | 0.51688515 |
| 103 | MP0001346_abnormal_lacrimal_gland | 0.51242714 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.50152672 |
| 105 | MP0002082_postnatal_lethality | 0.50141040 |
| 106 | MP0010770_preweaning_lethality | 0.50141040 |
| 107 | MP0003861_abnormal_nervous_system | 0.49264117 |
| 108 | MP0003956_abnormal_body_size | 0.48597210 |
| 109 | MP0003045_fibrosis | 0.48331865 |
| 110 | MP0010768_mortality/aging | 0.48202664 |
| 111 | MP0004130_abnormal_muscle_cell | 0.46932751 |
| 112 | MP0000579_abnormal_nail_morphology | 0.44396850 |
| 113 | MP0005620_abnormal_muscle_contractility | 0.42939180 |
| 114 | MP0001986_abnormal_taste_sensitivity | 0.41096779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.43953617 |
| 2 | Myokymia (HP:0002411) | 7.00599095 |
| 3 | Focal seizures (HP:0007359) | 6.09611756 |
| 4 | Visual hallucinations (HP:0002367) | 5.21399299 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.20978334 |
| 6 | Atonic seizures (HP:0010819) | 5.01726813 |
| 7 | Febrile seizures (HP:0002373) | 4.84411336 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.65125590 |
| 9 | Absence seizures (HP:0002121) | 4.43671247 |
| 10 | Action tremor (HP:0002345) | 4.11198250 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.06231728 |
| 12 | Dialeptic seizures (HP:0011146) | 4.05091304 |
| 13 | Hyperventilation (HP:0002883) | 4.02730449 |
| 14 | Broad-based gait (HP:0002136) | 3.99968904 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.83180202 |
| 16 | Poor eye contact (HP:0000817) | 3.59230833 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.54609735 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.40601700 |
| 19 | Abnormal social behavior (HP:0012433) | 3.31565786 |
| 20 | Impaired social interactions (HP:0000735) | 3.31565786 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.30337595 |
| 22 | Truncal ataxia (HP:0002078) | 3.24133768 |
| 23 | Dysmetria (HP:0001310) | 3.19531336 |
| 24 | Tetraplegia (HP:0002445) | 3.16681823 |
| 25 | Ankle clonus (HP:0011448) | 3.13851070 |
| 26 | Depression (HP:0000716) | 3.12499024 |
| 27 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.11038490 |
| 28 | Scanning speech (HP:0002168) | 3.06977548 |
| 29 | Abnormal eating behavior (HP:0100738) | 3.01621011 |
| 30 | Impaired smooth pursuit (HP:0007772) | 3.01611563 |
| 31 | Mutism (HP:0002300) | 2.97945972 |
| 32 | Postural instability (HP:0002172) | 2.96982420 |
| 33 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.96067722 |
| 34 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.96067722 |
| 35 | Anxiety (HP:0000739) | 2.95851335 |
| 36 | Genetic anticipation (HP:0003743) | 2.92809660 |
| 37 | Papilledema (HP:0001085) | 2.89651475 |
| 38 | Dysmetric saccades (HP:0000641) | 2.87856583 |
| 39 | Drooling (HP:0002307) | 2.87029302 |
| 40 | Excessive salivation (HP:0003781) | 2.87029302 |
| 41 | Amblyopia (HP:0000646) | 2.84905543 |
| 42 | Abnormality of the lower motor neuron (HP:0002366) | 2.82395983 |
| 43 | Progressive inability to walk (HP:0002505) | 2.77650870 |
| 44 | Diplopia (HP:0000651) | 2.75731958 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.75731958 |
| 46 | Epileptiform EEG discharges (HP:0011182) | 2.69838780 |
| 47 | Fetal akinesia sequence (HP:0001989) | 2.68931838 |
| 48 | Urinary urgency (HP:0000012) | 2.66714504 |
| 49 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.58455528 |
| 50 | Torticollis (HP:0000473) | 2.55842624 |
| 51 | Absent speech (HP:0001344) | 2.53380132 |
| 52 | Intention tremor (HP:0002080) | 2.53201446 |
| 53 | Cerebral hypomyelination (HP:0006808) | 2.52092899 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52005305 |
| 55 | Stereotypic behavior (HP:0000733) | 2.50889019 |
| 56 | Status epilepticus (HP:0002133) | 2.49395562 |
| 57 | Hemiparesis (HP:0001269) | 2.48853100 |
| 58 | Impaired vibratory sensation (HP:0002495) | 2.46654578 |
| 59 | Bradykinesia (HP:0002067) | 2.46433023 |
| 60 | Spastic gait (HP:0002064) | 2.44193948 |
| 61 | Focal dystonia (HP:0004373) | 2.43999603 |
| 62 | Hypsarrhythmia (HP:0002521) | 2.40531230 |
| 63 | Ventricular fibrillation (HP:0001663) | 2.40386051 |
| 64 | Inability to walk (HP:0002540) | 2.38359873 |
| 65 | Termporal pattern (HP:0011008) | 2.37392814 |
| 66 | Insidious onset (HP:0003587) | 2.37392814 |
| 67 | Abnormality of the corticospinal tract (HP:0002492) | 2.36444683 |
| 68 | Horizontal nystagmus (HP:0000666) | 2.34680471 |
| 69 | Hemiplegia (HP:0002301) | 2.33966266 |
| 70 | Delusions (HP:0000746) | 2.33538551 |
| 71 | Pheochromocytoma (HP:0002666) | 2.31798387 |
| 72 | Cerebral inclusion bodies (HP:0100314) | 2.28750228 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.25721444 |
| 74 | Annular pancreas (HP:0001734) | 2.25603460 |
| 75 | Polyphagia (HP:0002591) | 2.19438550 |
| 76 | Generalized myoclonic seizures (HP:0002123) | 2.16709964 |
| 77 | Peripheral hypomyelination (HP:0007182) | 2.16247788 |
| 78 | Craniofacial dystonia (HP:0012179) | 2.10816653 |
| 79 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.09372216 |
| 80 | Blue irides (HP:0000635) | 2.08641666 |
| 81 | Gait ataxia (HP:0002066) | 2.07567979 |
| 82 | Limb dystonia (HP:0002451) | 2.06040595 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.03162538 |
| 84 | Protruding tongue (HP:0010808) | 2.02993016 |
| 85 | Amyotrophic lateral sclerosis (HP:0007354) | 2.02749155 |
| 86 | Obstructive sleep apnea (HP:0002870) | 2.01716698 |
| 87 | Increased circulating renin level (HP:0000848) | 2.01276319 |
| 88 | Spastic tetraparesis (HP:0001285) | 2.00279915 |
| 89 | Incomplete penetrance (HP:0003829) | 1.99960729 |
| 90 | Syncope (HP:0001279) | 1.98820089 |
| 91 | Resting tremor (HP:0002322) | 1.98497201 |
| 92 | Abnormality of saccadic eye movements (HP:0000570) | 1.98444204 |
| 93 | Megalencephaly (HP:0001355) | 1.97845613 |
| 94 | Apathy (HP:0000741) | 1.97306550 |
| 95 | Neuroendocrine neoplasm (HP:0100634) | 1.96495780 |
| 96 | Abnormality of salivation (HP:0100755) | 1.93630265 |
| 97 | Agitation (HP:0000713) | 1.91385804 |
| 98 | Prolonged QT interval (HP:0001657) | 1.90833738 |
| 99 | Inappropriate behavior (HP:0000719) | 1.90608102 |
| 100 | Lower limb amyotrophy (HP:0007210) | 1.90403194 |
| 101 | Spastic tetraplegia (HP:0002510) | 1.90369765 |
| 102 | Neuronal loss in central nervous system (HP:0002529) | 1.89273435 |
| 103 | Pointed chin (HP:0000307) | 1.84546374 |
| 104 | Rapidly progressive (HP:0003678) | 1.84136137 |
| 105 | Muscular hypotonia of the trunk (HP:0008936) | 1.83900731 |
| 106 | Akinesia (HP:0002304) | 1.83290960 |
| 107 | Postural tremor (HP:0002174) | 1.82244925 |
| 108 | CNS hypomyelination (HP:0003429) | 1.82215789 |
| 109 | Sleep apnea (HP:0010535) | 1.78267837 |
| 110 | Generalized hypopigmentation of hair (HP:0011358) | 1.77543308 |
| 111 | Lower limb asymmetry (HP:0100559) | 1.77035919 |
| 112 | Limb ataxia (HP:0002070) | 1.76134169 |
| 113 | Psychosis (HP:0000709) | 1.73656589 |
| 114 | Clonus (HP:0002169) | 1.73622203 |
| 115 | Rigidity (HP:0002063) | 1.73272893 |
| 116 | Aqueductal stenosis (HP:0002410) | 1.71728725 |
| 117 | Specific learning disability (HP:0001328) | 1.70711000 |
| 118 | Abnormal EKG (HP:0003115) | 1.70452047 |
| 119 | Bundle branch block (HP:0011710) | 1.68395475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.52919793 |
| 2 | EPHA4 | 4.27455152 |
| 3 | MAP3K9 | 3.78744276 |
| 4 | MAP3K4 | 3.21321785 |
| 5 | MARK1 | 3.07259332 |
| 6 | MAP2K7 | 2.74812722 |
| 7 | MINK1 | 2.66769223 |
| 8 | DAPK2 | 2.52037125 |
| 9 | CASK | 2.39800813 |
| 10 | MAP3K12 | 2.21455466 |
| 11 | RIPK4 | 2.15256855 |
| 12 | NTRK2 | 2.11981096 |
| 13 | PAK6 | 2.04922801 |
| 14 | MAP2K4 | 2.03826334 |
| 15 | KSR2 | 1.97519549 |
| 16 | CAMKK1 | 1.96462308 |
| 17 | CDK19 | 1.76979302 |
| 18 | DAPK1 | 1.75198206 |
| 19 | NTRK1 | 1.71753020 |
| 20 | PRKD3 | 1.65227788 |
| 21 | CAMKK2 | 1.56520926 |
| 22 | CDK5 | 1.53367330 |
| 23 | FRK | 1.52863962 |
| 24 | KSR1 | 1.51876731 |
| 25 | TNIK | 1.43717940 |
| 26 | PRPF4B | 1.43215373 |
| 27 | PLK2 | 1.41881896 |
| 28 | PNCK | 1.39550980 |
| 29 | STK38 | 1.32766066 |
| 30 | PRKCG | 1.28788640 |
| 31 | GRK5 | 1.28251598 |
| 32 | ARAF | 1.26316000 |
| 33 | MAPK13 | 1.26045973 |
| 34 | MAP3K2 | 1.16563614 |
| 35 | FES | 1.15303431 |
| 36 | SIK2 | 1.11617338 |
| 37 | LATS2 | 1.09501957 |
| 38 | CAMK2A | 1.07574453 |
| 39 | CAMK1 | 1.04742517 |
| 40 | TAOK1 | 1.01432413 |
| 41 | MAP3K13 | 1.00138003 |
| 42 | BMPR2 | 0.98424836 |
| 43 | OXSR1 | 0.93782421 |
| 44 | PHKG2 | 0.91376365 |
| 45 | PHKG1 | 0.91376365 |
| 46 | SGK223 | 0.88894678 |
| 47 | SGK494 | 0.88894678 |
| 48 | UHMK1 | 0.88281620 |
| 49 | SGK2 | 0.88239588 |
| 50 | CDK18 | 0.87054838 |
| 51 | RAF1 | 0.87002608 |
| 52 | CAMK2B | 0.86155160 |
| 53 | STK11 | 0.85852362 |
| 54 | MAP3K11 | 0.84897875 |
| 55 | CDK15 | 0.84687117 |
| 56 | TYRO3 | 0.84079350 |
| 57 | YES1 | 0.81722246 |
| 58 | CDK14 | 0.80377047 |
| 59 | LMTK2 | 0.80103159 |
| 60 | RET | 0.77716724 |
| 61 | PRKCH | 0.76613770 |
| 62 | PTK2B | 0.74343110 |
| 63 | PINK1 | 0.74011387 |
| 64 | SGK3 | 0.73380839 |
| 65 | SGK1 | 0.72801993 |
| 66 | CDK11A | 0.72567451 |
| 67 | PDK1 | 0.68339054 |
| 68 | ROCK2 | 0.67785069 |
| 69 | PAK3 | 0.67570202 |
| 70 | CCNB1 | 0.66256947 |
| 71 | DAPK3 | 0.66190559 |
| 72 | MARK2 | 0.64838886 |
| 73 | CSNK1G2 | 0.64221152 |
| 74 | DYRK1A | 0.62832653 |
| 75 | PDPK1 | 0.60851839 |
| 76 | ALK | 0.60576915 |
| 77 | FGFR2 | 0.58679275 |
| 78 | CSNK1G3 | 0.57768354 |
| 79 | TNK2 | 0.56892147 |
| 80 | DYRK2 | 0.55860527 |
| 81 | PRKCE | 0.55640161 |
| 82 | AKT3 | 0.55376792 |
| 83 | CSNK1A1L | 0.55238383 |
| 84 | ROCK1 | 0.53810862 |
| 85 | PKN1 | 0.52524160 |
| 86 | CAMK4 | 0.52166009 |
| 87 | MAP3K1 | 0.51898903 |
| 88 | CAMK1G | 0.50814779 |
| 89 | WNK1 | 0.48752903 |
| 90 | CAMK2G | 0.48179960 |
| 91 | RPS6KA3 | 0.47405660 |
| 92 | CAMK2D | 0.45870221 |
| 93 | PRKCZ | 0.45221873 |
| 94 | FYN | 0.44713887 |
| 95 | PRKG2 | 0.43961265 |
| 96 | MAP3K6 | 0.43352088 |
| 97 | CSNK1G1 | 0.43291330 |
| 98 | MAP2K1 | 0.43262322 |
| 99 | RIPK1 | 0.42414531 |
| 100 | NEK6 | 0.40459628 |
| 101 | MAPK10 | 0.40270358 |
| 102 | CSNK1D | 0.40218462 |
| 103 | WNK3 | 0.40193905 |
| 104 | PRKCA | 0.40085934 |
| 105 | PRKG1 | 0.40031753 |
| 106 | MAP3K7 | 0.40029868 |
| 107 | SCYL2 | 0.39532056 |
| 108 | PRKCB | 0.38414752 |
| 109 | FER | 0.38251804 |
| 110 | CDC42BPA | 0.36341162 |
| 111 | MAPK12 | 0.35618762 |
| 112 | MUSK | 0.35120428 |
| 113 | FGR | 0.33680907 |
| 114 | NME1 | 0.33490441 |
| 115 | LIMK1 | 0.32961614 |
| 116 | NEK1 | 0.32594262 |
| 117 | DMPK | 0.32365977 |
| 118 | BRAF | 0.32272676 |
| 119 | PRKACA | 0.31741140 |
| 120 | SIK3 | 0.31071108 |
| 121 | CSNK1A1 | 0.25903829 |
| 122 | BRSK1 | 0.25753227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.87542652 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.41280688 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.76746050 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.76614510 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75300004 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75013342 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.73909303 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.63933382 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.56743554 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.53213456 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.27380927 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.17582052 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15299701 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96455082 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.93336201 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.91804880 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88594102 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85314626 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.81241912 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.72373614 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.71708512 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71269207 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65933700 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63236615 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62517226 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58155649 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40854015 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40468215 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36875484 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.33317380 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33111967 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30315780 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21165822 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16760268 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14570386 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11694519 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09371639 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.08804722 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06167272 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05114374 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04120932 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.03481769 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02156689 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00529227 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 0.99803446 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91942550 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90703678 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86408010 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85200257 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82539962 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81256152 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80367147 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79651152 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78425112 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77333010 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76751950 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76029095 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71118438 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70844686 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68115131 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67984966 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.65397369 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64361888 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61002534 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55663134 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55219928 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55147722 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55132866 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54547816 |
| 70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54346996 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53756425 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53007299 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52970659 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49680952 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49366095 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.49159734 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48341449 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47749008 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46959923 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46191230 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45449991 |
| 82 | Alcoholism_Homo sapiens_hsa05034 | 0.44736639 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44686567 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.40413455 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40378293 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39316794 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38599068 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37863037 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.37613833 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37028018 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36788236 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36727966 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36155870 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35407133 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35275910 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33189293 |
| 97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31497598 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31076408 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30535747 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29562738 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29351300 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.28223524 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28039471 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27893667 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23539269 |
| 106 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22483346 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.21515919 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19234365 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.16820013 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16775583 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.16284080 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.13395887 |

